Early chemoprophylaxis for deep venous thrombosis does not increase the risk of hematoma expansion in patients presenting with spontaneous intracerebral hemorrhage

CONCLUSION: The use of early chemoprophylaxis against venous thromboembolic events following ICH appears safe in our patient population without increasing the risk of hematoma expansion. Given the increased risk of poor outcome in the setting of VTE, early VTE chemoprophylaxis should be considered in patients who present with ICH. Larger, prospective, and randomized studies are necessary to better elucidate the risk of early chemoprophylaxis and potential reduction in venous thromboembolic events.PMID:34221608 | PMC:PMC8247662 | DOI:10.25259/SNI_100_2021

Source: Surgical Neurology International - July 5, 2021 Category: Neurosurgery Authors: Dimitri Laurent Olgert Bardhi Paul Kubilis Brian Corliss Stephanie Adamczak Ndi Geh William Dodd Sasha Vaziri Katharina Busl W Christopher Fox Source Type: research